While state-of-the-art treatments, including photocoagulation and anti-Vascular Endothelial Growth Factor (VEGF) therapies (34, 35) are available to treat DR-induced retinopathy resulting in vision loss, diagnostic tools that provide early intervention and treatment to control or reverse disease are limited. Here, VEGFA is linked to retinal disorder.